GalNac-siRNA negative control (21nt)
GalNac-siRNA negative control (21nt) is the negative control form of GalNac-siRNA. GalNac-siRNA is an Asialoglycoprotein receptor (ASGPR) -targeted inhibitor conjugate. GalNac-siRNA is promising for research of hereditary transthyretin amyloidosis, acute hepatic porphyria, hemophilia and hypercholesterolemia[1].
Product Specifications
UNSPSC
12352208
Target
LYTACs
Related Pathways
PROTAC
Field of Research
Cardiovascular Disease
Purity
96.95
Smiles
[GalNac-siRNAnegativecontrol(21nt)]
References & Citations
[1]Springer AD, et al. GalNAc-siRNA Conjugates: Leading the Way for Delivery of RNAi Therapeutics. Nucleic Acid Ther. 2018 Jun;28 (3) :109-118.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, sealed storage, away from moisture)
Scientific Category
Oligonucleotides
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
